Litcius/Paper detail

Real-world effectiveness of influenza vaccine over a decade during the 2011–2021 seasons—Implications of vaccine mismatch

Yu Jung Choi, Joon Young Song, Seong‐Heon Wie, Won Suk Choi, Jacob Lee, Jin Soo Lee, Young Keun Kim, Shin‐Woo Kim, Sun Hee Lee, Kyung‐Hwa Park, Hye Won Jeong, Jin Gu Yoon, Hye Seong, Eliel Nham, Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim

2024Vaccine17 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Influenza imposes a significant healthcare burden in Korea, leading the government to initiate a national immunization program. Previous studies on vaccine effectiveness (VE) were limited to single-season estimation in Korea. METHODS: This multicenter prospective cohort study enrolled patients with influenza-like illnesses at 10 medical centers in Korea from 2011 to 2021. The demographic and clinical data were collected from questionnaire surveys and electronic medical records. Using a test-negative design, we aimed to investigate the effectiveness of a seasonal influenza vaccine for antigenic matching of the vaccine and circulating viral strains over 10 seasons. RESULTS: Overall, 5322 adults aged ≥65 years were enrolled. Only three (33.3 %) of nine seasons showed >70 % antigenic match between vaccine and circulating strains. Influenza VE was significantly variable by season, ranging from -46.9 % (95 %confidence interval [CI]: -127.6-5.2) in the 2011/12 season to 47.7 % (95 %CI: 22.6-64.7) in the 2016/17 season. A significant difference was observed in the VE depending on whether the vaccine strains matched with epidemic strains: 28.8 % (95 %CI: 8.8-44.8) in matched seasons versus -12.0 % (95 %CI: -30.0-3.7) in mismatched seasons. Across the study period, influenza-related hospitalizations were reduced by 13.6 % (95 %CI: 0.7-24.8) with vaccination. In a subgroup analysis, the VE against influenza-related hospitalization was 48.4 % (95 %CI 29.6-62.2) in A/H3N2 dominant seasons and 53.8 % (95 %CI: -73.4-87.7) in A/H1N1 dominant seasons, respectively. CONCLUSION: Influenza vaccine mismatch was frequent over the study period, leading to negligibly low VE in mismatched seasons. Influenza vaccination reduces the risk of influenza-related hospitalizations.

Topics & Concepts

Influenza vaccineVirologyLive attenuated influenza vaccineMedicineVaccinationInfluenza Virus Research StudiesRespiratory viral infections researchData-Driven Disease Surveillance
Real-world effectiveness of influenza vaccine over a decade during the 2011–2021 seasons—Implications of vaccine mismatch | Litcius